VERA Q3 2025 Earnings — Vera Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

VERAVera Therapeutics, Inc.

$3B

Q3 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$564,000

Operating Income

-$84M

Net Income

-$80M

EPS (Diluted)

$-1.26

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$62M

Free Cash Flow

-$62M

Stock-Based Comp.

$10M

Balance Sheet

Total Assets

$518M

Total Liabilities

$119M

Stockholders' Equity

$399M

Cash & Equivalents

$58M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$564,000	$0	—
Operating Income	-$84M	-$50M	-68.5%
Net Income	-$80M	-$47M	-72.2%